Potential Vaccine Could Make HIV "Minor Infection"

instinctmagazine.com

Sunday mornings are usually reserved for mimosas and walks of shame. But when we uncharacteristically got out of bed and onto our laptops this morning to do some work we were elated to learn some encouraging news on the Interwebs coming out of Spain regarding HIV. Read more about it after the jump.

We've been reporting on quite a few different poistive developments and clinical trials for HIV/AIDS vaccines over the past year, and we are thrilled to offer up some more progress being made toward a potential HIV vaccine. This news comes out of Spain as reported byThe Daily Pioneer:

"Spanish researchers have found that 22 of 24 healthy people (92 per cent) developed an immune response to HIV after being given their MVA-B vaccine. Professor Mariano Esteban, head researcher on the project at the National Biotech Centre in Madrid, said of the jab, “It is like showing a picture of the HIV so that it is able to recognise it if it sees it again in the future.”

Overall, 92 per cent developed some sort of immune response. However, that is not the same thing as being protected from HIV infection: The response could be inadequate to provide protection. The researcher was optimistic, saying, “MVA-B vaccine has proven to be as powerful as any other vaccine currently being studied, or even more. If this genetic cocktail passes Phase II and Phase III future clinic trials, and makes it into production, in the future HIV could be compared to herpes virus nowadays.”

For more specifics on the study, go to our source, The Daily Pioneer.